Sometimes the most valuable prior authorization is the one you never send.
Key Takeaways
- Some denials are written into federal law. No amount of documentation or appeals can change them.
- Drugs used for erectile dysfunction are excluded from Medicare Part D unless prescribed for a different FDA-approved indication.
- Catching an exclusion before submission saves staff time and lets the practice talk with the patient sooner.
The case
A 67-year-old patient with a Humana Medicare Advantage plan that includes Part D drug coverage was prescribed sildenafil for erectile dysfunction by his primary care physician.
The front desk prepared a standard prior authorization packet. Before submitting it, the case was flagged for review.
Why this request could not be approved
Federal law excludes drugs used to treat sexual or erectile dysfunction from Medicare Part D coverage. The exception applies only to a drug prescribed for a different condition that the FDA has approved it to treat. For example, sildenafil is also approved for pulmonary arterial hypertension. Off-label uses do not qualify for the exception.
Sources: Federal Register, Medicare Part D final rule (April 15, 2008); Mississippi Division of Medicaid
This is a statutory exclusion, not a plan preference. A stronger chart note, a peer-to-peer call, or an appeal will not change the outcome.
What our team checked
- The plan type and the benefit the drug falls under
- The prescribed indication
- Whether any other FDA-approved indication applied
What we did
We did not submit the request. Our specialist notified the practice that the medication is excluded under this plan for this indication so that the physician could discuss options with the patient right away.
Submitting would have cost staff time, started a denial and appeal cycle with no chance of success, and left the patient waiting for an answer we already knew.
A related situation: GLP-1s and weight-loss exclusions
Many commercial plans exclude weight-loss drugs but cover GLP-1 medications for type 2 diabetes. The request should reflect the physician’s documented clinical indication. When a GLP-1 is prescribed to manage type 2 diabetes, the diagnosis on the request should say so. When it is prescribed for weight loss under a plan that excludes weight-loss drugs, no coding choice changes that, and the exclusion applies.
The documents that close the gap
Where our team sees this most often
Humana Part D and most Medicare Advantage plans with drug coverage.
A question for your team
How many hours did your team spend last month on requests the plan could never approve?
Want a prior authorization team that reads the chart and the plan before every submission? Talk with DataMatrix Medical.
More from this series: see all six prior authorization case studies.
This case is drawn from a real prior authorization request our team handled. We removed identifying details to protect patient privacy. Payer policies change and vary by plan, so the same steps will not produce the same result in every case. This article is educational and is not legal, billing, or clinical advice.
Nathaniel Smathers is the VP of Client Education and Marketing. He is also a long time contributor of the DataMatrix Medical blog and has a background in healthcare content creation for over a decade. Nathaniel is passionate about exploring the intersections of healthcare, data analysis, and digital innovation.
